Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
1.
Rev. esp. cardiol. (Ed. impr.) ; 68(7): 562-570, jul. 2015. tab, ilus
Article in Spanish | IBECS | ID: ibc-138856

ABSTRACT

Introducción y objetivos. La activación tanto del sistema nervioso simpático como del sistema renina-angiotensina-aldosterona está estrechamente relacionada con la hipertensión arterial pulmonar. Nuestra hipótesis era que la simpatectomía renal reduce la actividad del sistema renina-angiotensina-aldosterona e inhibe la progresión de la hipertensión arterial pulmonar. Métodos. Se asignó aleatoriamente a un total de 22 perros beagle a tres grupos de estudio. Se efectuaron determinaciones de la dinámica pulmonar de esos animales antes y 8 semanas después de la inyección de 0,1 ml/kg de dimetilformamida (perros de control) o de 2 mg/kg de deshidromonocrotalina (perros con hipertensión arterial pulmonar y perros con hipertensión arterial pulmonar + simpatectomía renal). Ocho semanas después de la inyección, se determinaron las concentraciones de neurohormonas y se evaluó la morfología del tejido pulmonar. Resultados. Se observó un aumento significativo de la concentración de angiotensina II y endotelina-1 en plasma después de 8 semanas en los perros con hipertensión arterial pulmonar, y los valores obtenidos en los tejidos pulmonares de estos animales eran superiores a los de los perros del grupo de control y el grupo de simpatectomía renal (medias: angiotensina II, 65 ± 9,8 frente a 38 ± 6,7 y 46 ± 8,1; endotelina-1, 96 ± 10,3 frente a 54 ± 6,2 y 67 ± 9,4; p < 0,01). La deshidromonocrotalina aumentó la presión arterial pulmonar media (16 ± 3,4 frente a 33 ± 7,3 mmHg; p < 0,01), y la simpatectomía renal evitó que se produjera este aumento. La proliferación celular del músculo liso pulmonar fue mayor en los perros con hipertensión arterial pulmonar que en los animales de los grupos de control y de hipertensión arterial pulmonar + simpatectomía renal. Conclusiones. La simpatectomía renal atenúa el remodelado vascular pulmonar y reduce la presión arterial pulmonar en la hipertensión arterial pulmonar experimental. El efecto de la simpatectomía renal puede contribuir a reducir las concentraciones de neurohormonas (AU)


Introduction and objectives. Activation of both the sympathetic nervous system and the renin-angiotensin-aldosterone system is closely associated with pulmonary arterial hypertension. We hypothesized that renal denervation decreases renin-angiotensin-aldosterone activity and inhibits the progression of pulmonary arterial hypertension. Methods. Twenty-two beagles were randomized into 3 groups. The dogs’ pulmonary dynamics were measured before and 8 weeks after injection of 0.1 mL/kg dimethylformamide (control dogs) or 2 mg/kg dehydromonocrotaline (pulmonary arterial hypertension and pulmonary arterial hypertension + renal denervation dogs). Eight weeks after injection, neurohormone levels and pulmonary tissue morphology were measured. Results. Levels of plasma angiotensin II and endothelin-1 were significantly increased after 8 weeks in the pulmonary arterial hypertension dogs and were higher in the lung tissues of these dogs than in those of the control and renal denervation dogs (mean [standard deviation] angiotensin II: 65 [9.8] vs 38 [6.7], 46 [8.1]; endothelin-1: 96 [10.3] vs 54 [6.2], 67 [9.4]; P < .01). Dehydromonocrotaline increased the mean pulmonary arterial pressure (16 [3.4] mmHg vs 33 [7.3] mmHg; P < .01), and renal denervation prevented this increase. Pulmonary smooth muscle cell proliferation was higher in the pulmonary arterial hypertension dogs than in the control and pulmonary arterial hypertension + renal denervation dogs (AU)


Subject(s)
Animals , Dogs , Female , Humans , Male , Sympathectomy/methods , Sympathectomy/veterinary , Hypertension/drug therapy , Hypertension/surgery , Hypertension/veterinary , Renin-Angiotensin System , Renin-Angiotensin System/physiology , Models, Animal , Ketamine/therapeutic use , 35170/methods , Sympathetic Nervous System , Angiotensin II/therapeutic use , Endothelin-1/therapeutic use , Pentobarbital/therapeutic use , Dimethylformamide/therapeutic use , Hemodynamics
2.
Int Endod J ; 36(10): 670-3, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14511223

ABSTRACT

AIM: To examine the use of an Nd:YAG laser in removing gutta-percha fillings from root canals when used in conjunction with eucalyptol, dimethylformamide (DMF) or no solvent. METHODOLOGY: Root-canal fillings (sealer and gutta-percha) were removed with laser irradiation of 20 Hz/1.5 W from 30 roots randomly divided in three groups. In group 1, the solvent was eucalyptol; in group 2, the solvent was DMF; and in group 3, no solvent was used. Laser irradiation was performed until the temperature measured on the root surface increased by 4 degrees C over room temperature. The treatment was deemed complete when the apical foramen was reached with the optical fibre and a reamer. The samples were split longitudinally, and the area of remaining gutta-percha on the root-canal walls was determined with the aid of a computer program. The total number of laser pulses to achieve length and the highest temperature recorded was determined for each tooth. The results were statistically analysed using Student's t-test (P < 0.05) for independent samples. RESULTS: The average temperature increase in group 1 was 9.17 +/- 0.56 degrees C; in group 2, 9.56 +/- 0.28 degrees C; and in group 3, 8.29 +/- 0.41 degrees C. The shortest time to achieve length was in group 3 (6.4 +/- 0.49 min), then in group 1 (6.7 +/- 0.85 min) and group 2 (7.05 +/- 0.79 min). The area of remaining gutta-percha was the largest in group 2 (6.13 +/- 5.76%), whilst the smallest was for group 3 (4.69 +/- 4.03%), but the difference was not statistically significant. The number of pulses was not statistically significant between the groups. CONCLUSIONS: Use of an Nd:YAG laser alone is capable of softening gutta-percha. The addition of solvents did not improve the retreatment, either in terms of the time required for the procedure or in terms of the area of remaining gutta-percha on root-canal walls.


Subject(s)
Dental Pulp Cavity/ultrastructure , Gutta-Percha/chemistry , Lasers , Root Canal Filling Materials/chemistry , Aluminum Silicates , Cyclohexanols/therapeutic use , Dental Pulp Cavity/radiation effects , Dimethylformamide/therapeutic use , Eucalyptol , Eucalyptus , Gutta-Percha/radiation effects , Hardness , Humans , Image Processing, Computer-Assisted , Monoterpenes/therapeutic use , Neodymium , Root Canal Filling Materials/radiation effects , Root Canal Preparation/instrumentation , Solvents/therapeutic use , Surface Properties , Temperature , Time Factors , Yttrium
14.
BMJ ; 314(7083): 771, 1997 Mar 15.
Article in English | MEDLINE | ID: mdl-9080992

ABSTRACT

PIP: In South Africa, claims that the drug Virodene P058 inhibits progression of HIV infection have been condemned. The claims were forwarded by a team from Pretoria University which conducted its experiments without obtaining the required permission, demonstrated a lack of specific scientific skill, lacked a proper control group, and worked in secret. Virodene P058 contains diethylformamide, a toxic industrial solvent which has not been shown to inhibit HIV protease. The researchers also garnered criticism for bypassing normal procedures and presenting their results directly to the minister of health in a bid to obtain funding. Critics also voiced concern about the creation of a private company by one of the researchers. The research team, which has threatened to take legal action against the team of experts convened to look into the matter, faces additional charges of professional negligence or misconduct.^ieng


Subject(s)
Acquired Immunodeficiency Syndrome/drug therapy , Anti-HIV Agents/therapeutic use , Dimethylformamide/analogs & derivatives , Dimethylformamide/therapeutic use , Ethical Review , Humans , Research/standards , Solvents , South Africa
18.
Vojnosanit Pregl ; 51(6): 488-91, 1994.
Article in Serbian | MEDLINE | ID: mdl-8585153

ABSTRACT

The efficacy of clay or alcoholate as decontaminants in pigs percutaneously poisoned with 6 LD50 of O-ethyl S-2-diisopropylaminoethyl methylphosphonothioate (VX) and 3 LD50 of 1,2,2-trimethylpropyl methylphosphonofluoridate (soman) nerve gases was tested. It was assessed by the time of onset of the first signs of poisoning and death, as well as by the activity of blood cholinesterase (ChE). No toxic signs or fatalities were observed in decontaminated pigs, regardless of the decontaminant used. In VX poisoning up to 240 min. both decontaminants kept ChE values at normal level. Twenty four hours later, ChE activity in pigs decontaminated with clay was 71%, significantly higher than in pigs decontaminated with alcoholate (49%). In soman poisoning the activity in control group was maintained at almost normal level up to 60 min, followed by rapid fall to 58%. Further readings were impossible due to the death of all animals. No significant difference between decontaminants could be noticed throughout the observation of 24 hr. The values were kept between 80 and 100%, with the trend of rising after 120 min.


Subject(s)
Aluminum Silicates/therapeutic use , Chemical Warfare Agents/poisoning , Decontamination , Dimethylformamide/therapeutic use , Organothiophosphorus Compounds/poisoning , Soman/poisoning , Thiophenes/therapeutic use , Animals , Cholinesterase Inhibitors/poisoning , Clay , Gas Poisoning/therapy , Swine
19.
Vojnosanit Pregl ; 49(4): 343-7, 1992.
Article in Serbian | MEDLINE | ID: mdl-1481449

ABSTRACT

Efficacy of decontamination by alcoholate and clay has been examined in animals percutaneously poisoned by nerve war gases (VX, soman) and organophosphorous insecticides (parathion, dichlorvos, terbufos) at exposure of 2, 5 and 60 minutes. High efficacy was achieved after two minutes using alcoholates which, except for VX, was lower for 50% after 5 minutes. The similar results were also achieved with clay in nerve war gas poisoning, however, the efficacy of this material was somewhat lower. By delayed decontamination (after 60 minutes) in animals poisoned by parathion and terbufos somewhat lower but still satisfying efficacy was achieved (ZI = 3.3, that is, 11.5). The results obtained have shown that efficacy of decontamination, except for the used materials, depends also on duration of the procedure.


Subject(s)
Acetals/therapeutic use , Aluminum Silicates/therapeutic use , Organophosphate Poisoning , Animals , Clay , Dimethylformamide/therapeutic use , Female , Poisoning/therapy , Rats , Rats, Wistar , Sulfones/therapeutic use
20.
Int J Cancer ; 43(2): 285-92, 1989 Feb 15.
Article in English | MEDLINE | ID: mdl-2465278

ABSTRACT

The anti-tumor activity of the putative differentiation-inducing agent dimethylformamide (DMF) was assessed in 7 head-and-neck xenograft (HNX) lines transplanted into nude mice. The drug was administered intra-peritoneally at the maximum tolerated dose. A significant growth-inhibitory effect was observed in 3 out of 7 tumor lines tested. When compared with 5 conventional drugs active in patients with squamous-cell carcinoma of the head and neck (HNSCC), DMF was as effective as the most active drugs (cisplatin and bleomycin). The most sensitive xenograft line, the poorly differentiated tumor HNX-14C, was used to test the hypothesis that differentiation induction might play a role in the anti-tumor activity of DMF. Light microscopic examination did not show clear-cut alteration of differentiation characteristics such as keratin and keratin pearl formation. Furthermore, we used a monoclonal antibody to study the expression of cytokeratin 10 which is useful as a differentiation marker of human HNSCC tumors. Keratin 10, not present in HNX-14C tumors grown under control conditions, became expressed in some cells upon DMF treatment. Further evidence for a differentiation-inducing activity of DMF was found in electron-microscopic studies. In treated HNX-14C tumors, in addition to cells with normal ultrastructural features, better-differentiated cells were observed, as manifested by an increase in the number of tonofilaments and desmosomes. The results show that DMF has a potential value for the treatment of patients with head-and-neck cancer, and that differentiation induction might play a role in the anti-tumor action of the drug.


Subject(s)
Carcinoma, Squamous Cell/drug therapy , Dimethylformamide/therapeutic use , Head and Neck Neoplasms/drug therapy , Animals , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/ultrastructure , Cell Differentiation/drug effects , Drug Evaluation, Preclinical , Female , Head and Neck Neoplasms/pathology , Head and Neck Neoplasms/ultrastructure , Humans , Keratins/analysis , Mice , Mice, Nude , Microscopy, Electron , Neoplasm Transplantation , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...